VAQTA Rx

Select the drug indication to add to your list

VAQTA

Vaccines
Only 4 drugs may be compared at once

Generic Name and Formulations:

Hepatitis A vaccine, inactivated 25Units per 0.5mL (pediatric/adolescent), or 50Units per 1mL (adult); susp for IM inj; aluminum adsorbed; preservative-free.

Select therapeutic use:

Indications for VAQTA:

Hepatitis A immunization.

Adult:

≥19 yrs: 1mL IM at elected date and booster dose (1mL IM) 6–18 months later.

Children:

<12 months: not recommended. 1–18 yrs: 0.5mL IM at elected date and booster dose (0.5mL IM) 6–18 months later.

Warnings/Precautions:

Have epinephrine (1:1000) available. Latex allergy. Inject into deltoid muscle, preferably at least 2 weeks before expected exposure. If given with immune globulin, use separate syringe and different site. Fever. Malignancies. Immunocompromised (may have suboptimal response). Bleeding disorders. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Immunosuppressives may reduce efficacy. Concomitant vaccines, immune globulins: see literature.

Adverse Reactions:

Injection site reactions (esp. pain, tenderness), headache, fever, GI upset, myalgia, abdominal pain, rash, pharyngitis and other upper respiratory tract effects.

How Supplied:

Prefilled syringes (0.5mL, 1mL)—1, 5; Single-dose vials (0.5mL)—1, 10; Single-dose vials (1mL)—1, 5, 10

VAQTA 1ml of 50 units syringes (Qty:1)

appx. price $77.00